The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

por Jönsson, Linus, Wimo, Anders, Handels, Ron, Johansson, Gunilla, Boada, Mercè, Engelborghs, Sebastiaan, Frölich, Lutz, Jessen, Frank, Kehoe, Patrick Gavin, Kramberger, Milica, de Mendonςa, Alexandre, Ousset, Pierre Jean, Scarmeas, Nikolaos, Visser, Pieter Jelle, Waldemar, Gunhild, Winblad, Bengt
Publicado 2023